Global Impact of COVID-19 on Stroke Care and IV Thrombolysis
dc.contributor.author | Nogueira, Raúl G. | |
dc.contributor.author | Qureshi, Muhammad M. | |
dc.contributor.author | Abdalkader, Mohamad | |
dc.contributor.author | Martins, Sheila Ouriques | |
dc.contributor.author | Yamagami, Hiroshi | |
dc.contributor.author | Mansour, Ossama Yassin | |
dc.contributor.author | Qiu, Zhongming | |
dc.contributor.author | Sathya, Anvitha | |
dc.contributor.author | Czlonkowska, Anna | |
dc.contributor.author | Tsivgoulis, Georgios | |
dc.contributor.author | Aguiar de Sousa, Diana | |
dc.contributor.author | Demeestere, Jelle | |
dc.contributor.author | Mikulik, Robert | |
dc.contributor.author | Vanacker, Peter | |
dc.contributor.author | Siegler, James E. | |
dc.contributor.author | Kõrv, Janika | |
dc.contributor.author | Biller, Jose | |
dc.contributor.author | Liang, Conrad W. | |
dc.contributor.author | Sangha, Navdeep S. | |
dc.contributor.author | Zha, Alicia M. | |
dc.contributor.author | Czap, Alexandra L. | |
dc.contributor.author | Holmstedt, Christine Anne | |
dc.contributor.author | Turan, Tanya N. | |
dc.contributor.author | Ntaios, George | |
dc.contributor.author | Malhotra, Konark | |
dc.contributor.author | Tayal, Ashis | |
dc.contributor.author | Loochtan, Aaron | |
dc.contributor.author | Ranta, Annamarei | |
dc.contributor.author | Mistry, Eva A. | |
dc.contributor.author | Alexandrov, Anne W. | |
dc.contributor.author | Huang, David Y. | |
dc.contributor.author | Yaghi, Shadi | |
dc.contributor.author | Raz, Eytan | |
dc.contributor.author | Sheth, Sunil A. | |
dc.contributor.author | Mohammaden, Mahmoud H. | |
dc.contributor.author | Frankel, Michael | |
dc.contributor.author | Bila Lamou, Eric Guemekane | |
dc.contributor.author | Aref, Hany M. | |
dc.contributor.author | Elbassiouny, Ahmed | |
dc.contributor.author | Hassan, Farouk | |
dc.contributor.author | Menecie, Tarek | |
dc.contributor.author | Mustafa, Wessam | |
dc.contributor.author | Shokr, Hossam M. | |
dc.contributor.author | Roushdy, Tamer | |
dc.contributor.author | Sarfo, Fred S. | |
dc.contributor.author | Alabi, Tolulope Oyetunde | |
dc.contributor.author | Arabambi, Babawale | |
dc.contributor.author | Nwazor, Ernest O. | |
dc.contributor.author | Sunmonu, Taofiki Ajao | |
dc.contributor.author | Wahab, Kolawole | |
dc.contributor.author | Yaria, Joseph | |
dc.contributor.author | Hussein Mohammed, Haytham | |
dc.contributor.author | Adebayo, Philip B. | |
dc.contributor.author | Riahi, Anis D. | |
dc.contributor.author | Sassi, Samia Ben | |
dc.contributor.author | Navia, Víctor | |
dc.contributor.author | Olavarría, Verónica | |
dc.date.accessioned | 2021-11-29T16:55:11Z | |
dc.date.available | 2021-11-29T16:55:11Z | |
dc.date.issued | 2021 | |
dc.description.abstract | Objective To measure the global impact of COVID-19 pandemic on volumes of IV thrombolysis (IVT), IVT transfers, and stroke hospitalizations over 4 months at the height of the pandemic (March 1 to June 30, 2020) compared with 2 control 4-month periods. Methods We conducted a cross-sectional, observational, retrospective study across 6 continents, 70 countries, and 457 stroke centers. Diagnoses were identified by their ICD-10 codes or classifications in stroke databases. Results There were 91,373 stroke admissions in the 4 months immediately before compared to 80,894 admissions during the pandemic months, representing an 11.5% (95% confidence interval [CI] −11.7 to −11.3, p < 0.0001) decline. There were 13,334 IVT therapies in the 4 months preceding compared to 11,570 procedures during the pandemic, representing a 13.2% (95% CI −13.8 to −12.7, p < 0.0001) drop. Interfacility IVT transfers decreased from 1,337 to 1,178, or an 11.9% decrease (95% CI −13.7 to −10.3, p = 0.001). Recovery of stroke hospitalization volume (9.5%, 95% CI 9.2–9.8, p < 0.0001) was noted over the 2 later (May, June) vs the 2 earlier (March, April) pandemic months. There was a 1.48% stroke rate across 119,967 COVID-19 hospitalizations. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was noted in 3.3% (1,722/52,026) of all stroke admissions. Conclusions The COVID-19 pandemic was associated with a global decline in the volume of stroke hospitalizations, IVT, and interfacility IVT transfers. Primary stroke centers and centers with higher COVID-19 inpatient volumes experienced steeper declines. Recovery of stroke hospitalization was noted in the later pandemic months. | es |
dc.identifier.citation | Global Impact of COVID-19 on Stroke Care and IV Thrombolysis Nogueira R.G., Qureshi M.M., Abdalkader M., Martins S.O., Yamagami H., Qiu Z., Mansour O.Y., (...), SVIN COVID-19 Global Stroke Registry (2021) Neurology, 96 (23) , pp. e2824-e2838. | |
dc.identifier.uri | http://hdl.handle.net/11447/5131 | |
dc.language.iso | en | es |
dc.subject | Stroke | |
dc.subject | COVID-19 | |
dc.subject | Risk factors | |
dc.title | Global Impact of COVID-19 on Stroke Care and IV Thrombolysis | es |
dc.type | Article | es |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- Global Impact of COVID-19 on Stroke Care and IV Thrombolysis.pdf
- Size:
- 471.55 KB
- Format:
- Adobe Portable Document Format
- Description:
- Texto completo
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: